European Commission allows Glycom A/S to place lacto-N-tetraose (‘LNT’), obtained by microbial fermentation with a genetically modified strain of Escherichia coli, strain K12 DH1, on the Union market as a novel food. CLICK HERE Tags: HMO, LNT, novel food Read more articles Previous PostFermented Food Consumption Associated with Changes in the Gut Microbiome Next PostThe Global Prebiotic Association Welcomes FrieslandCampina Ingredients as a New Member You Might Also Like A Prebiotic Diet and its Impact on Food Decision-Making Stimuli December 29, 2023 Flavonoid-rich Foods, Microbial Diversity and Abundance of Parabacteroides and Impact on Blood Pressure September 2, 2021 New Study Demonstrates Consistent and Targeted Prebiotic Effects of Benicaros® August 7, 2025
Flavonoid-rich Foods, Microbial Diversity and Abundance of Parabacteroides and Impact on Blood Pressure September 2, 2021